The searchable archive below contains a list of Knight ADRC Tuesday Seminar presenters, the date of their presentation, institutional affiliation, and the title of their talk. The archive starts in 2000 with listings displayed in reverse chronological order (most recent first). Note that prior to 2020, some events may be missing or inaccurate due to last minute changes/cancellations.
Total Entries: 1312
| Date | Presenter | Affiliation | Title |
|---|---|---|---|
| March 6, 2001 | Martha Storandt, PhD | WashU | Rate of Progression in Dementia of the Alzheimer Type |
| February 27, 2001 | Judy Cam | WashU | Role of LRP in APP Endocytic Trafficking and Amyloid Beta-Peptide Production |
| February 20, 2001 | David Holtzman, MD | WashU | Understanding Amyloid-Beta Metabolism: Insights From APP Transgenic Mice |
| February 13, 2001 | Garland E. Allen, PhD | WashU | Genetics, Eugenics and the Medicalization of (Human) Behavior: Lessons From the Past |
| February 6, 2001 | Cheryl Oliver | OASIS and BJC Plus | The OASIS Person to Person Program |
| January 30, 2001 | David Johnson | WashU | A Linguistic Analysis of Logical Memory Story Recall |
| January 23, 2001 | Girish Putcha | WashU | Identification of a Gene Important for Neuronal Death |
| January 16, 2001 | J. Taylor Harden, PhD, RN, FAAN | National Institute on Aging | Straight Talk About Race: Inclusion Of Minorities As Subjects in NIA Clinical Research |
| January 9, 2001 | Brad Racette, MD | WashU | The Genetics of Parkinson’s Disease |
| January 2, 2001 | John C. Morris, MD | WashU | Update on Alzheimer Disease (AD) Therapy |
| December 26, 2000 | No Seminar | Winter Break | |
| December 19, 2000 | Amanda J. Myers | WashU | Second Stage Follow-Up of a Genome-Wide Screen for Novel Risk Factors Involved in Late Onset Alzheimer’s Disease |
| December 12, 2000 | Serge Przedborski, MD | Columbia University | The Neurotoxin MPTP: A Tool to Explore the Pathogenesis of Parkinson’s Disease |
| December 5, 2000 | Patricia M. Scannell & Philip A. Ludbrook, MD | WashU | IRB Issues and Discussion |
| November 28, 2000 | Bruce A. Yankner, MD, PhD | Harvard Medical School and Children’s Hospital | Towards a Unified Hypothesis for the Etiology of Alzheimer’s Disease |
| November 21, 2000 | Carl Bassi, PhD | University of Missouri, St. Louis | What the Alzheimer Eye Tells the Alzheimer Brain |
| November 14, 2000 | Randy Buckner, PhD | WashU | Functional Brain Imaging of Nondemented and Demented Older Adults |
| November 7, 2000 | Thomas Meuser, PhD & Samuel J. Marwitt, PhD | WashU & University of Missouri, St. Louis | Anticipatory Grief in Alzheimer’s Disease Caregivers: A Descriptive Model |
| October 31, 2000 | Joseph D. Buxbaum, PhD | Mount Sinai School of Medicine | The Role of A-Beta in Alzheimer’s Disease |
| October 24, 2000 | William Burke, MD | St. Louis University Medical Center | Catecholamine Aldehyde Metabolites in Neurodegeneration and Atherosclerosis |
| October 17, 2000 | Shan Ping Yu, MD, PhD | WashU | Na+, K+-ATPase and Neuronal Cell Death: Ionic Basis for Apoptosis and Necrosis |
| October 10, 2000 | John C. Morris, MD | WashU | Mild Cognitive Impairment Represents Early-Stage Alzheimer’s Disease |
| October 3, 2000 | Xianlin Han, PhD | WashU | Changes in Specific Brain Lipids: Potential Role in Alzheimer’s Disease |
| September 26, 2000 | Herman Buschke, MD | Albert Einstein College of Medicine | Screening for Memory Impairment in Alzheimer’s Disease |
| September 19, 2000 | Martin R. Farlow, MD | Indiana University School of Medicine | Alzheimer’s Disease Treatment and Predictions of Response |